Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARNA

Arena Pharmaceuticals (ARNA) Stock Price, News & Analysis

Arena Pharmaceuticals logo

About Arena Pharmaceuticals Stock (NASDAQ:ARNA)

Advanced Chart

Key Stats

Today's Range
$99.99
$99.99
50-Day Range
$93.13
$99.99
52-Week Range
$45.50
$100.00
Volume
107 shs
Average Volume
1.56 million shs
Market Capitalization
$6.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arena Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARNA Stock News Headlines

Arwana Citramulia Tbk (ARNA)
This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
RNA startup launches with $300M, Merck partnership
Arna L. Davidson
See More Headlines

ARNA Stock Analysis - Frequently Asked Questions

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced its earnings results on Thursday, November, 4th. The biopharmaceutical company reported ($3.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.53) by $0.68.

Arena Pharmaceuticals shares reverse split on Monday, June 19th 2017.The 1-10 reverse split was announced on Wednesday, June 14th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 16th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arena Pharmaceuticals investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Cytokinetics (CYTK), Micron Technology (MU), Bristol Myers Squibb (BMY) and Canopy Growth (CGC).

Company Calendar

Last Earnings
11/04/2021
Today
8/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ARNA
CIK
1080709
Employees
448
Year Founded
1977

Profitability

EPS (Trailing Twelve Months)
($10.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$616.43 million
Net Margins
N/A
Pretax Margin
-1,141,542.63%
Return on Equity
-69.83%
Return on Assets
-62.35%

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
8.59
Quick Ratio
8.59

Sales & Book Value

Annual Sales
$50 thousand
Price / Sales
123,305.67
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.94 per share
Price / Book
9.14

Miscellaneous

Outstanding Shares
61,659,000
Free Float
60,173,000
Market Cap
$6.17 billion
Optionable
Optionable
Beta
0.55

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ARNA) was last updated on 8/19/2025 by MarketBeat.com Staff
From Our Partners